• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·3993.HK
Share

CMOC Group Limited Stocks

HK$ 17.17Last Updated 21.08.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

HK$ 46.38B

HK$ 17.17
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

CMOC Group Limited, through its diverse subsidiaries, is a multifaceted enterprise engaged in the entire value chain from the extraction, processing, and refining to the commercialization of numerous metallic resources. These include essential minerals like copper, cobalt, molybdenum, tungsten, niobium, and phosphates, alongside other base and rare metals. The company's extensive product offerings encompass molybdenum oxide, ferromolybdenum, concentrates of molybdenum, tungsten, and copper, cobalt hydroxide, ferroniobium, phosphate fertilizer, and precious metals such as gold and silver. Beyond its core mining activities, CMOC also undertakes the processing and distribution of mineral products, trades in molybdenum and tungsten commodities, and participates in the international import and export of both goods and technology. Its operational scope further extends into service sectors, covering hotel management, consulting, corporate operations, asset management, logistics, and transportation services. CMOC maintains a substantial global footprint, with active operations across China, Australia, Brazil, the Democratic Republic of the Congo, Switzerland, and various other international locations. The company was initially established in 2006 under the name China Molybdenum Co., Ltd., and its corporate headquarters are situated in Luoyang, People's Republic of China.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 3993.HK is 24.6 and suggests 44.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.08.2026 21:01

Anthropic to Strengthen Founders' Rights and Unitree's 460% Surge: Key Takeaways on the IPO by August 23

23.08.2026 18:01

Investors' Magical Thinking: The Power of Rituals, Superstitions, and Luck in the Stock Market

23.08.2026 15:01

"Stop Drawing Colorful Charts": How to Make Plans in an Era of Change

22.08.2026 16:01

What's Happening in Small-Cap Stocks: Curaleaf's Offering, a New GLP-1 Drug, and a Defense IPO

22.08.2026 13:01

U.S. national debt weighs on the market; top model joins a Kazakhstani AI company; Nasdaq to open at night

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026